Norbrook has announced the launch of Total Pet Health Month 2012, a pet education campaign aimed at improving the health and welfare of dog and cats.

The campaign, which began on 13^th August, offers advice and guidance to pet owners about a range of pet health problems. Norbrook says the main aim is to encourage owners to speak with their vet if they have any concerns about their pet. 

The main vehicle for the campaign is the Norbrook's Pet Healthcare website on http://www.norbrook.com/pets-health/.

The first topic featured in Total Pet Health Month 2012 is parasite control and treatment. Norbrook commissioned petbuzz to carry out research on parasite concerns for pet owners.  

Michelle Jones, Norbrook Small Animal Brand Manager said: "Almost 80% of pet owners reported seeing an increase in fleas and ticks in the summer so it is timely to launch Total Pet Health Month with a focus on parasite control. 70% of respondents were concerned about the risk of skin problems and discomfort in their pets due to fleas and ticks. We hope that our campaign will address these concerns and help pet owners manage what can be a very unpleasant and irritating problem."

The research highlighted that 63% of pet owners sought advice from a vet in relation to flea and tick treatment and 66% purchased treatments from a veterinary practice.

Michelle said: "It is very encouraging that two thirds of pet owners purchase treatments from a vet. Total Pet Health Month is a great opportunity for pet owners to find out more about concerns they have for their pets. We would actively encourage them to engage with animal health experts and veterinarians because they will get invaluable advice during the purchase which they may not otherwise get." 

During Total Pet Health Month 2012, Norbrook will also look at conditions including gum disease and hip dysplasia.

Total Pet Health Month will run across the Total Pet Publishing network (a Europe-wide network of pet sites). Norbrook says it will engage with more than 3m pet owners, guiding them to the Norbrook pet healthcare portal and to seek solutions and treatments from their veterinary practice.

The petbuzz market research was conducted in May 2012 with 1,147 pet owners: 86% dog owners, 41% cat owners, 10% rabbit owners.

Virbac has announced that its recently launched parasiticide Neoprinil has been granted a shelf life extension from one to two years after first opening.

The company says the extension will help minimise the risk of wasted product and increase its convenience to farmers.

An eprinomectin pour-on solution, Neoprinil is indicated for use against internal and external parasites in cattle, including gut and lungworms, mange mites, sucking and chewing lice, horn flies and warbles. It is administered using the company's Farmpack and Flexibag, and offers a zero-day withdrawal period in milk.

Virbac's Product Manager for Large Animals Brigitte Goasduf MRCVS said: "Understanding the challenges our customers face and offering products to overcome them is our goal so we are delighted that Neoprinil has received a shelf life extension because this adds to its flexibility and convenience for farmers. It also brings it into line with Deltanil, our deltamethrin-based pour-on for use against a range of ectoparasites in cattle and sheep.

"We now offer a comprehensive and flexible parasiticide range administered with a dispensing system that sets a new standard for convenience and ease of use."

Neoprinil is presented in 2.5l, 4.5l and 8l pack sizes.

Dechra has launched new Specific Heart & Kidney Support Hydrolysed dry diets and updated its Specific Heart & Kidney Support wet and dry diets, giving veterinary teams another diet option for dogs and cats with kidney disease.

The new hydrolysed diet contains hydrolysed proteins, AuraGuard, fibres and Zeolite.

Dechra says the new formula featured in both diets offers superior palatability and works in a multi-action way with support of the gut-kidney axis to help optimise protein absorption and maintenance of muscle mass, gut barrier integrity and a healthy microbiome, while lowering uremic toxins in the blood.

The company says both diets control levels of protein, phosphorus and sodium and offer high levels of the Omega-3 fatty acids EPA and DHA.

Becky Morris, marketing manager at Dechra, said: "Chronic kidney disease is a lifelong progressive disease in dogs and cats, and nutrition is an important part of management to help slow disease progression, improve quality of life and reduce the risk of secondary complications.

"Our new and updated highly palatable Specific Heart & Kidney Support diets will help keep dogs and cats in good condition, prolonging the progression of the disease and the lifespan of the pet."

https://www.specific-diets.co.uk 

The RCVS Charitable Trust is seeking two creative and energetic UK-based veterinary students to attend the British Science Festival in Aberdeen from 4-9 September 2012.

The Trust says that the students will be required to use their observations and experiences to help it develop future outreach activities to inform and inspire public audiences about aspects of veterinary clinical practice and research, and will have all their expenses paid by the Trust.

Entrants need to write to the RCVS Charitable Trust to say how they would go about meeting this challenge, ideally giving examples that demonstrate their proven innovative abilities. The deadline for entries is 9 July, after which the entries will be considered by a competition panel who will decide the winners. Entrants must be able to commit to attending the entire festival and to deliver a feedback presentation to the competition panel on 31 October. Entrants should also be willing and able to compile a video diary or blog to feedback their experiences.

Further information and details about how to enter are available at http://trust.rcvs.org.uk/home/. The successful applicants will be announced at the end of July.

Janssen Animal Health has launched a new website providing information on the subject of coccidiosis in calves and lambs: www.takingcareofcoccidiosis.com.

The website builds on the findings of an expert workshop on bovine coccidiosis held at the First European Buiatrics Conference, which was facilitated by Janssen. In particular, the site looks at all of the areas that the experts focused on as being especially problematic, including immunity, sources of infection, risk factors, prevention and treatment.

According to the company, arriving at a diagnosis of coccidiosis is not always straightforward: it must be supported by history and clinical signs, as well as evidence of pathogenic species of the Eimeria parasite. Interpretation of oocyte counts can be particularly difficult and results have to be viewed in the context of the farm situation. The site contains explanations about the timing of sampling and how that can impact upon the results.

Janssen adds that treatment has traditionally relied on fluid therapy and the use of sulphonamide drugs but recommendations on the use of more recently introduced treatments such as diclazuril (Vecoxan) focus on single dose treatments administered 14 days after a stress factor - such as moving to a higher risk environment, weaning or transportation. The various treatment strategies including prophylactic and metaphylactic approaches are described for those who have experienced problems with coccidiosis in the past and want to avoid recurrence on an individual farm.

Janssen says the site is an ideal on-line resource for veterinary professionals, SQPs and farmers looking to update their knowledge, seeking a tool that explains the disease in greater depth or just searching for specific information that helps in their own individual situation or with interpretation of a difficult case, www.takingcareofcoccidiosis.com/.

Petplan has been voted Best Insurance Provider in the seventh annual Your Cat and Your Dog Product Awards.

This is the sixth consecutive year Your Cat and Your Dog readers have voted Petplan number one, in response to a survey completed by thousands of pet owners.

Isabella von Mesterhazy, Head of Marketing at Petplan said: "To be independently voted number one provider by pet owners means so much, particularly as this is the sixth time we have been awarded this honour.

"Petplan's Covered for Life policy is the original lifetime policy - we were the first insurer to offer this type of policy and cover. This, combined with over 36 years' experience in the pet insurance marketplace means Petplan truly understands what pet owners need and want from their pet insurance. We settle 97% of claims successfully and 90% of customers renew each year. Moreover, we paid out over £180 million in claims in 2013, the majority directly with the vet, which leaves owners able to concentrate on supporting their pet back to full health rather than worrying about vet bills."

Dechra has launched a new support package to help veterinary surgeons and nurses dealing with otitis externa, and to encourage compliance amongst owners whose dogs are being treated for the disease. 

Called the Dermatology Partners in Practice programme, the initiative includes a client compliance pack which contains the Guide to Good Ear Care, a leaflet on handling techniques, a treatment diary and a consultation report.

Roger Brown, Senior Brand Manager at Dechra Veterinary Products, said: "We are committed to supporting vets and vet nurses as they deal with cases of otitis externa at a time when responsible use of antimicrobials is in the spotlight.

"It is essential that owners comply with treatment programmes and that vets are supported with involving owners, which can lead to better outcomes for dogs receiving treatment and can be good for developing the practice business as well.

"We know from our research, and from talking to the vets and vet nurses, that owner compliance can be a barrier to successful first-time management and resolution of otitis externa.

"The new Client Compliance Pack is designed to support veterinary professionals as they diagnose, control and maintain this complex condition."

"All in all, it will provide extra support to the owner as they carry through the professional treatment plan once back home."

Veterinary surgeons are being invited to arrange a Business Support Discussion to find out more about the Dermatology Partners in Practice Programme and how it can benefit their practice. For details and to know more about the pack, call 01939 211215 or visit dechra.co.uk/timetochange.

With the end of the vector-free period and the threat of more cases of bluetongue, organisations from across all elements of the livestock sector have come together to launch a Joint campaign Against Bluetongue (JAB), with the strapline ‘don’t hesitate, vaccinate’.

The organisations involved, which represent livestock farmers, livestock markets and meat and dairy processing as well as the veterinary profession, all fully support the joint industry/Defra vaccination plan for bluetongue and are committed to working together on the campaign to achieve the mass vaccination of bluetongue susceptible animals, including goats and camelids.

JAB is now embarking on a major campaign to urge all farmers with susceptible livestock to vaccinate their animals as soon as vaccine is available and the BVA, along with our relevant specialist divisions, is committed to ensuring that vets have all the information in advance so that they are in a position to deal with their clients’ questions.

According to BVA President Nick Blayney: "Colleagues should be aware and look out for meetings being organised around the country, courtesy of the VLA and others, and led by vets where they can learn the latest information. The BVA website also carries useful and up-to-date information and links  (http://www.bva.co.uk/policy/bluetongue_jab.asp). Practices are seen as the cornerstone of vaccine delivery, proper usage and monitoring for efficacy and BVA would encourage them to offer their clients the ability to register an interest in vaccine supply in advance of its arrival. Such a forward order book will speed up the delivery of the vaccine once it is available."

Boehringer Ingelheim has announced the results of an independent three-year study which demonstrates that dogs suffering from the most common type of heart failure lived longer (average time in the study of 267 days vs. 140 days) when treated with the product Vetmedin (pimobendan) compared with the ACE inhibitor benazepril hydrochloride.

According to Boehringer, results from the QUEST (Quality of Life and Extension of Survival Time) study, published in the September/October 2008 issue of the Journal of Veterinary Internal Medicine, mark a significant milestone in canine cardiac health.

25% of all small to medium-sized dogs over the age of seven are likely to suffer from heart disease at some point in their life, and 75% of those cases are caused by myxomatous mitral valve disease (MMVD), sometimes known as "valvular insufficiency" or "endocardiosis".

Adrian Boswood from the Royal Veterinary College, London, a Veterinary Cardiology Specialist and a lead-investigator on the study, said: "With QUEST demonstrating that dogs treated with Vetmedin live on average nearly twice as long as those on benazepril, it is now time for us as veterinary cardiologists and practising veterinarians to look again at how we are treating our patients suffering from  this serious condition."

Dr. Michael O'Grady from the Ontario Veterinary College, University of Guelph, a fellow lead-investigator added, "The QUEST study provides compelling evidence that dogs with the most common form of heart failure should be receiving Vetmedin^® as an essential part of their treatment regimen."

QUEST is the largest international study ever conducted looking at treatment for congestive heart failure (CHF) caused by MMVD, with 260 dogs studied in 11 countries, across three continents, over a period of three years.

The study was conducted by a team of 32 independent veterinary cardiologists from Australia, Canada, France, Germany and the United Kingdom among other countries.

For more information on the QUEST study and on CHF caused by MMVD, see http://www.questtrial.com/

MSD Animal Heath has launched a new dispensing pack to help veterinary practices develop retail sales for Cosequin DS, the joint supplement for pets.

The new dispensing pack, which doubles up as a display pack, contains 300 chews foil-wrapped for extra freshness in 30 packs of 10 strips, allowing Cosequin to stand in the waiting room or on reception.

The new pack, available now in wholesalers, replaces the previous 90, 120 and 180 DS chewable tablet pack sizes.

Elanco Animal Health, maker of Comfortis, Trifexis and Atopica, has launched ScratchTracker, a smartphone app designed to help dog owners with a simple way to monitor pruritus in their pet and share the results with their vet.

Elanco says ScratchTracker uses a scoring scale that has been developed by veterinary dermatologists and is proven to be an accurate and consistent way for pet owners to assess pruritus in dogs.

It's hoped the app will help veterinary surgeons track how a dog is responding to treatment and identify reasons for an increase in the dog's level of itchiness.

After downloading ScratchTracker from the Apple App Store or Google Play, pet owners are asked to rate how itchy their pet is by agreeing to a statement such as 'Extremely severe itching/almost continuous: itching doesn't stop whatever is happening, even in the consulting room' or 'Moderate itching/regular episodes: itching might occur at night, but not when eating, playing or exercising'. The reading will then be submitted and ScratchTracker will convert it to a numerical score tracking history which can be emailed from the app to the veterinary surgeon.

Alice Laurens, DVM MRCVS, product manager at Elanco Animal Health, said: "The ScratchTracker App is a useful tool to track pruritus in dogs for either a short period of time or for dogs suffering from a lifelong condition such as atopic dermatitis as part of a long term management programme."

For further information, contact your Elanco Animal Health key account manager or email: elancoCAH.uk@elanco.com

The supermarket Morrisons is to launch new pet food packaging which will alert shoppers to the ideal portion size their cat or dog should be eating, in a bid to tackle the UK's growing pet obesity problem.

Morrisons is the first supermarket to add portion control guidance to the front of their pet food packaging, and it follows research from Petplan which found that 36% of all dogs and 29% of cats treated by vets are obese. In addition, 71% of vets agree that cases of obesity are continuing to rise.

Each packet of Morrisons pet food will provide the correct portion for a healthy weight pet and, according to the company, the packaging will communicate the amount of servings each product provides clearly.

Apparently, 70% of owners believe that their dog or cat has never been overweight, which shows that there is a level of confusion amongst owners as to how much their pet is eating. A further 83% do not even worry about giving their pet too much food. Morrisons is aiming to make it easier for pet lovers to ensure their animal doesn't put on any unnecessary weight especially with Christmas just around the corner and the temptation of being fed leftovers and treats.

According to vets asked by Petplan there are five main reasons for an obesity problem amongst household pets. They are:

• Too much food
• Lack of exercise
• Not knowing the healthy weight or shape of their pet
• Snacking
• Wrong type of food

John Cannan, New Product Development Manager for Pet Food at Morrisons said: "We've had feedback from our customers which says that they are often in the dark about how much food they should be buying and giving their pet. Our new packaging will ensure that shoppers have a clearer sense of portion sizes whilst also saving them some pennies"

Brian Faulkner Petplan Vet of the Year said: "It's great to see Morrisons taking the lead on this and helping shoppers make more informed decisions about what they are feeding their pet. Whilst it's normal to give your animal a treat every now and then, pets do need to follow healthy regimes just like we do. Keeping your pet fit and healthy will ultimately save you money on veterinary bills as well."

Researchers from Highcroft Veterinary Referrals, the Royal Veterinary College and the University of Zurich are asking veterinary surgeons to take part in a survey designed to identify the rate of complications associated with Angiostrongylus vasorum (lungworm) infection or treatment in dogs.

The research, which is led by Drs Kieran Borgeat, Jose Matos and David Connolly, is the first step of a larger project, which hopes to culminate in the development of a set of consensus guidelines for the diagnosis and treatment of lungworm in dogs.

The researchers say that the guidelines are needed because there is currently no consensus amongst veterinary practitioners as to how dogs infected with Angiostrongylus vasorum (lungworm) are best treated. In addition, whilst there are anecdotal reports of adverse reactions after treatment, none are currently published in the literature.

The survey takes less than 10 minutes to complete, and all participants who leave their email address will be entered into a prize draw for £100 worth of Amazon vouchers.

No pharmaceutical or food companies have been involved in the design or funding of the research, and approval has been granted by the RVC Ethics and Welfare Committee.

The survey  will close on 1^st May 2016, or when 1000 responses have been completed. All information entered into the questionnaire will be completely anonymous and contact information will be held in a confidential database and not shared with any third parties.

To take part, visit http://tinyurl.com/lungwormsurvey